EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Hydrogen Sulfide in Inflammatory Bowel Disease

Nathalie Stummer, René G Feichtinger iD, Daniel Weghuber iD, Barbara Kofler iD, Anna M Schneider iD

Antioxidants · 06.08.2023 · 12 (8) · 1570

DOI: 10.3390/antiox12081570 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 06.08.2023. Verfasst von Nathalie Stummer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydrogen sulfide (H2S), originally known as toxic gas, has now attracted attention as one of the gasotransmitters involved in many reactions in the human body. H2S has been assumed to play a role in the pathogenesis of many chronic diseases, of which the exact pathogenesis remains unknown. One of them is inflammatory bowel disease (IBD), a chronic intestinal disease subclassified as Crohn’s disease (CD) and ulcerative colitis (UC). Any change in the amount of H2S seems to be linked to inflammation in this illness. These changes can be brought about by alterations in the microbiota, in the endogenous metabolism of H2S and in the diet. As both too little and too much H2S drive inflammation, a balanced level is needed for intestinal health. The aim of this review is to summarize the available literature published until June 2023 in order to provide an overview of the current knowledge of the connection between H2S and IBD.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s disease (CD)hydrogen sulfide (H2S)inflammatory bowel disease (IBD)ulcerative colitis (UC)

Autor:innen und Institutionen

  • Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Research Program for Receptor Biochemistry and Tumor Metabolism, Paracelsus Medical University (PMU), 5020 Salzburg, Austria.

ORCID-Profile: René G Feichtinger, Daniel Weghuber, Barbara Kofler, Anna M Schneider

Zitieren

APA

Stummer, N., Feichtinger, R. G., Weghuber, D., Kofler, B., & Schneider, A. M. (2023). Role of Hydrogen Sulfide in Inflammatory Bowel Disease. Antioxidants, 12(8), 1570. https://doi.org/10.3390/antiox12081570

Vancouver

Stummer N, Feichtinger RG, Weghuber D, Kofler B, Schneider AM. Role of Hydrogen Sulfide in Inflammatory Bowel Disease. Antioxidants. 2023;12(8):1570. doi:10.3390/antiox12081570

BibTeX
@article{Stummer2023,
  author = {Stummer, Nathalie and Feichtinger, René G and Weghuber, Daniel and Kofler, Barbara and Schneider, Anna M},
  title = {Role of Hydrogen Sulfide in Inflammatory Bowel Disease},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {8},
  pages = {1570},
  doi = {10.3390/antiox12081570}
}
Kostenlos starten →